dr. rathkopf on ar-v7 biomarker in prostate cancer
Published 7 years ago • 188 plays • Length 0:42Download video MP4
Download video MP3
Similar videos
-
1:08
dr. rathkopf on mitigating ar resistance in prostate cancer
-
6:14
androgen receptor splice variant, ar-v7, as prostate cancer biomarker
-
0:52
dr. rathkopf on investigative agents in prostate cancer
-
1:00
dr. armstrong on the utility of ar-v7 as a biomarker in prostate cancer
-
1:01
dr. armstrong discusses ar-v7 testing in prostate cancer
-
6:30
ar-v7 as a predictive marker in prostate cancer
-
2:34
ar-v7 as a biomarker in crpc
-
3:22
detection of ar-v7 in prostate cancer
-
7:46
prostate cancer: validation of ar-v7 testing
-
3:04
prostate cancer: educating physicians about ar-v7 testing
-
5:52
recent ar-v7 data in prostate cancer
-
5:34
multidisciplinary care for prostate cancer and ar-v7 status
-
6:18
prostate cancer: discovery and importance of ar-v7
-
29:02
ar-v7 in castration resistant prostate cancer
-
1:20
dr. antonarakis on ar-v7 and resistance to enzalutamide and abiraterone in prostate cancer
-
1:09
dr. dreicer on resistance to antiandrogen therapy in prostate cancer
-
6:29
ar-v7 and drug resistance
-
6:56
ar-v7 testing for men with advanced stage prostate cancer
-
1:32
dr. antonarakis discusses ar-v7 and response to taxanes in men with mcrpc